This guide explains the science behind Retatrutide, including its structure, proposed mechanisms, current research areas, and frequently asked questions
Novel Agents Published in Endocrinology in August, Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management sets the stage for how remarkably these agents have transformed the treatment landscape and what additional benefits may lie on the horizon
Conclusion Semaglutide is an effective treatment for diabetes and weight management, but it can cause side effects like diarrhea, vomiting, and other gastrointestinal issues
(2023) NEJM
Both Tirzepatide and Semaglutide have been associated with weight loss in clinical trials
Here's a shortlist of those